Mohammad Ahmadvand

About Mohammad Ahmadvand

Mohammad Ahmadvand, With an exceptional h-index of 14 and a recent h-index of 13 (since 2020), a distinguished researcher at Tehran University of Medical Sciences,

His recent articles reflect a diverse array of research interests and contributions to the field:

Upregulation of lnc-FOXD2-AS1, CDC45, and CDK1 in patients with primary non-M3 AML is associated with a worse prognosis

Results: Thirty-six allo-HSCT recipients, with a mean age of 42.42 years and a median time of 133 days between hematopoietic stem cell transplant (allo-HSCT)

Comprehensive analysis of the role of ubiquitin-specific peptidases in colorectal cancer: A systematic review

Homologous versus Heterologous prime-boost COVID-19 Vaccination in autologous hematopoietic stem cell transplantation recipients: a blinded randomized controlled trial

Cancer immunotherapy via stem cell-derived NK cells

Investigation of KIR/HLA relationship and other clinical variables after T-cell-replete haploidentical bone marrow transplantation in patients with acute myeloid leukemia (AML)

Three doses of a recombinant conjugated SARS-CoV-2 vaccine early after allogeneic hematopoietic stem cell transplantation: predicting indicators of a high serologic response—a …

Evaluation of safety and immunogenicity of a recombinant receptor-binding domain (RBD)-tetanus toxoid (TT) conjugated SARS-CoV-2 vaccine (PastoCovac) in recipients of …

Mohammad Ahmadvand Information

University

Position

Hematology-Oncology and Stem Cell Transplantation Research Center

Citations(all)

614

Citations(since 2020)

458

Cited By

334

hIndex(all)

14

hIndex(since 2020)

13

i10Index(all)

17

i10Index(since 2020)

13

Email

University Profile Page

Google Scholar

Top articles of Mohammad Ahmadvand

Upregulation of lnc-FOXD2-AS1, CDC45, and CDK1 in patients with primary non-M3 AML is associated with a worse prognosis

Blood Research

2024/12

Results: Thirty-six allo-HSCT recipients, with a mean age of 42.42 years and a median time of 133 days between hematopoietic stem cell transplant (allo-HSCT)

COVID-19 booster vaccination: increasing immunity against life-threatening infection

2024/1/25

Comprehensive analysis of the role of ubiquitin-specific peptidases in colorectal cancer: A systematic review

2024/1/1

Homologous versus Heterologous prime-boost COVID-19 Vaccination in autologous hematopoietic stem cell transplantation recipients: a blinded randomized controlled trial

Frontiers in Immunology

2023/8/1

Cancer immunotherapy via stem cell-derived NK cells

2023/8

Investigation of KIR/HLA relationship and other clinical variables after T-cell-replete haploidentical bone marrow transplantation in patients with acute myeloid leukemia (AML)

BMC immunology

2023/6/20

Mohammad Ahmadvand
Mohammad Ahmadvand

H-Index: 8

Alireza Sadeghi
Alireza Sadeghi

H-Index: 9

Three doses of a recombinant conjugated SARS-CoV-2 vaccine early after allogeneic hematopoietic stem cell transplantation: predicting indicators of a high serologic response—a …

Frontiers in Immunology

2023/4/19

Evaluation of safety and immunogenicity of a recombinant receptor-binding domain (RBD)-tetanus toxoid (TT) conjugated SARS-CoV-2 vaccine (PastoCovac) in recipients of …

Vaccines

2023/1/3

Chemo-immune cell therapy by intratumoral injection of adoptive NK cells with capecitabine in gastric cancer xenograft model

BioImpacts: BI

2023

Cytokine-Treated Natural Killer Cells Derived from Cord Blood Haematopoietic Stem Cells Exhibit Potential Cytotoxicity Against Cancer Cells

International Journal of Cancer Management

2023/12/31

The influence of KIR gene polymorphisms and KIR-ligand binding on outcomes in hematologic Malignancies following haploidentical stem cell transplantation: A comprehensive review

2023/12/1

Mohammad Ahmadvand
Mohammad Ahmadvand

H-Index: 8

Alireza Sadeghi
Alireza Sadeghi

H-Index: 9

Phase I non-randomized clinical trial of allogeneic natural killer cells infusion in acute myeloid leukemia patients

BMC cancer

2023/11/10

The Role of Ubiquitin-specific Peptidases in Colorectal Cancer: A Systematic Review Protocol

2023/10/7

Nabeel Al-Yateem
Nabeel Al-Yateem

H-Index: 13

Mohammad Ahmadvand
Mohammad Ahmadvand

H-Index: 8

Abnormal Promoter Methylation of Nucleotide-Binding Oligomerization Domain Containing 2 (NOD2) Gene in the Pathogenesis of Crohn’s Disease

Acta Medica Iranica

2023/8/23

Safety and feasibility study of ex vivo expanded allogeneic-NK cells infusion in patients with acute pneumonia caused by COVID-19

Pilot and Feasibility Studies

2023/8/4

The long-term outcome and efficacy of PR1/BCR-ABL multipeptides vaccination in chronic myeloid leukemia: results of a 7-year longitudinal investigation

Iranian Journal of Blood and Cancer

2022/12/30

Mohammad Ahmadvand
Mohammad Ahmadvand

H-Index: 8

Parisa Ghaffari
Parisa Ghaffari

H-Index: 1

Use of expanded carrier screening for retrospective diagnosis of two deceased siblings with Van Maldergem syndrome 2: case report

Asian Biomedicine

2022/12/1

Mohammad Ahmadvand
Mohammad Ahmadvand

H-Index: 8

A comparative study of the bone marrow-and umbilical cord-derived Mesenchymal Stem Cells (MSCs) Efficiency on Generating MSC-Educated Macrophages (MEMs)

Asian Pacific Journal of Cancer Prevention: APJCP

2022/9

Shaban Alizadeh
Shaban Alizadeh

H-Index: 17

Mohammad Ahmadvand
Mohammad Ahmadvand

H-Index: 8

Identification of miR-195-5p as a novel prognostic biomarker for colorectal cancer

Molecular Biology Reports

2022/7

In Vitro Generation of BK polyomavirus-specific T cells for adoptive cell therapy in refractory cystitis hemorrhagic patients after hematopoietic stem cell transplantation

BMC immunology

2022/6/10

See List of Professors in Mohammad Ahmadvand University(Tehran University of Medical Sciences)